MedTrace Logo

Opioids Titration in Hospice Patients

NCT01007422 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2013-04-02

No results posted yet for this study

Summary

RATIONALE: Opioids lessen pain caused by cancer. Titration of opioids in the hospice setting is suboptimal due to numerous barriers. Order sets may help to provide timely and effective medical and pharmaceutical intervention.

PURPOSE: The purpose of this study was to identify barriers to good pain control in the hospice setting and to develop an order set that would safely address these barriers.

Conditions

Interventions

BEHAVIORAL

telephone-based intervention

OTHER

communication intervention

OTHER

intervention by caregiver

OTHER

medical chart review

OTHER

survey administration

PROCEDURE

end-of-life treatment/management

PROCEDURE

pain therapy

PROCEDURE

psychosocial assessment and care

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Barbara A. Murphy, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-05-31
Completion
2009-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01007422 on ClinicalTrials.gov